IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer (Q39468304)
Jump to navigation
Jump to search
scientific article published on 14 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer |
scientific article published on 14 November 2011 |
Statements
1 reference
IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer (English)
1 reference
Carly Jade Dool
1 reference
Haider Mashhedi
1 reference
Mahvash Zakikhani
1 reference
Stéphanie David
1 reference
Yunhua Zhao
1 reference
Elena Birman
1 reference
Joan M Carboni
1 reference
Marco Gottardis
1 reference
Marie-José Blouin
1 reference
Michael Pollak
1 reference
14 November 2011
1 reference
1 reference
18
1 reference
6
1 reference
699-709
1 reference
Identifiers
1 reference
1 reference